Malaria Clinical Trial
Official title:
A Cluster-randomised Trial of Health Worker and Community Interventions to Improve Adherence to National Guidelines for the Use of ACTs in Tanzania
Background.
Overdiagnosis of malaria is widespread in health facilities throughout Africa, a situation
that is unsustainable given the relatively high cost of artemisinin combination therapy
(ACTs) compared to older antimalarials. In addition it often denies patients treatment for
their actual illness and generates unreliable data for health planners. For these reasons
the National Malaria Control Programme introduced revised guidelines for malaria diagnosis
and treatment in 2006 restricting the recommendation for antimalarial treatment in patients
over the age of 5 years to those with a positive blood slide or malaria rapid diagnostic
tests (RDTs) result. To support this, RDTs will be introduced into primary care health
facilities in Tanzania starting in 2009.
The high accuracy of current rapid diagnostic tests (RDTs) provides the potential for a
cost-effective solution to the problem of malaria overdiagnosis. However, RDTs with revised
guidelines to restrict malaria diagnoses to RDT-positive patients have been unsuccessful
unless accompanied by unsustainable levels of supervision and training.
Primary objective.
To conduct a trial of interventions directed at prescribers or prescribers and communities
compared to control groups to improve adherence to national guidelines for prescription of
antimalarial treatment when supported by RDTs in primary health care facilities in NE
Tanzania.
Methods
All 60 participating health facilities will receive RDTs and basic training in their use and
a copy of current NMCP/MOH guidelines for each prescribing staff member. A health worker
intervention arm will, in addition, receive workplace-based interactive training and
messages from senior staff A health worker-community arm will receive the same training as
the health worker arm and in addition leaflets will be provided to RDT-tested patients
providing information on the test and the treatment given. All training materials will be
approved by NMCP in Tanzania as being consistent with current national guidelines but with
the addition that prescribers will be asked to follow RDT results in prescribing for
patients of any age This policy is in line with the most recent revision to WHO guidelines
and is supported by NMCP in Tanzania.
Study outcomes will be recorded through a 40% (2 days per week) exit survey of patients.
Anthropological and economics studies will assess the costs and acceptability of
interventions.
n/a
Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Health Services Research
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04601714 -
Baseline Cohort Malaria Morbidity Study
|
||
| Withdrawn |
NCT04020653 -
A Study to Assess the Safety and Efficacy of 5-aminolevulinic Acid Hydrochloride (5-ALA HCl) and Sodium Ferrous Citrate (SFC) Added on Artemisinin-based Combination Therapy (ACT) in Adult Patients With Uncomplicated Malaria
|
Phase 2 | |
| Terminated |
NCT04368910 -
Safety and Efficacy of Pyronaridine Artesunate Vs Chloroquine in Children and Adult Patients With Acute Vivax Malaria
|
Phase 3 | |
| Completed |
NCT03641339 -
Defining Skin Immunity of a Bite of Key Insect Vectors in Humans
|
N/A | |
| Completed |
NCT02544048 -
Markers of T Cell Suppression: Antimalarial Treatment and Vaccine Responses in Healthy Malian Adults
|
||
| Completed |
NCT00527163 -
Role of Nitric Oxide in Malaria
|
||
| Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
| Active, not recruiting |
NCT04704674 -
Community Dynamics of Malaria Transmission in Humans and Mosquitoes in Fleh-la and Marshansue, Salala District, Bong County, Liberia
|
||
| Completed |
NCT03276962 -
Efficacy, Safety and Immunogenicity Study of GSK Biologicals' Candidate Malaria Vaccine (SB257049) Evaluating Schedules With or Without Fractional Doses, Early Dose 4 and Yearly Doses, in Children 5-17 Months of Age
|
Phase 2 | |
| Completed |
NCT04966871 -
Safety, Tolerability and Efficacy of PfSPZ Vaccine Against Heterologous CHMI in US Malaria naïve Adults
|
Phase 1 | |
| Completed |
NCT00289185 -
Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria Vaccine in Tanzanian Infants
|
Phase 2 | |
| Recruiting |
NCT03937817 -
Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants
|
||
| Active, not recruiting |
NCT06153862 -
Africa Ready Malaria Screening
|
N/A | |
| Completed |
NCT04545905 -
Antenatal Care as a Platform for Malaria Surveillance: Utilizing Community Prevalence Measures From the New Nets Project to Validate ANC Surveillance of Malaria in Burkina Faso
|
||
| Recruiting |
NCT06278181 -
Diabetes, Metabolic Syndrome and Risk of Malaria in Cameroon
|
||
| Completed |
NCT02793622 -
Prevention of Malaria in HIV-uninfected Pregnant Women and Infants
|
Phase 3 | |
| Withdrawn |
NCT02793388 -
A Trial on Supervised Primaquine Use in Ethiopia
|
Phase 4 | |
| Completed |
NCT02909712 -
Cardiac Safety of Dihydroartemisinin-Piperaquine Amongst Pregnant Women in Tanzania
|
Phase 2 | |
| Withdrawn |
NCT02793414 -
Diagnostic Utility of Volatile Organic Compounds in Human Breath for Acute Clinical Malaria in Ethiopia
|
||
| Completed |
NCT02605720 -
Cardiac Safety of Repeated Doses of Dihydroartemisinin-Piperaquine for the Use in Mass Treatment Campaigns
|
Phase 3 |